Antenatal corticosteroids for fetal maturation in women at risk for preterm delivery

Clinics in Perinatology

Volumn 30, Issue 4, 2003, Pages 825-840

  Vidaeff, Alex C ^a   Doyle, Nora M ^a   Gilstrap III, Larry C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; CORTICOSTEROID; CORTICOSTEROID RECEPTOR; DEXAMETHASONE; PLACEBO; TRIAMCINOLONE;

BEHAVIOR; CHORIOAMNIONITIS; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EXPOSURE; DRUG POTENCY; ENDOMETRITIS; FETUS MATURITY; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; LOW BIRTH WEIGHT; LUNG DISEASE; META ANALYSIS; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NEWBORN DEATH; NEWBORN SEPSIS; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW;

EID: 0742304258     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(03)00102-7     Document Type: Review

References (79)

1. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 50:1972;515-525.
2. Gardner M.O., Goldenberg R.L. The clinical use of antenatal corticosteroids. Clin Obstet Gynecol. 38:1995;746-754.
3. Vidaeff A.C., Mastrobattista J.M. Controversies in the use of antenatal steroids for fetal maturation. Sem Perinatol. 25:2001;385-396.
4. Pattinson R.C. A meta-analysis of the use of corticosteroids in pregnancies complicated by preterm premature of membranes. S Afr Med J. 89:1999;870-873.
5. Elimian A., Verma U., Canterino J.et al. Effectiveness of antenatal steroids in obstetric subgroups. Obstet Gynecol. 93:1999;174-179.
6. Canterino J.C., Verma U., Visintainer P.F., Elimian A.et al. Antenatal steroids and neonatal periventricular leukomalacia. Obstet Gynecol. 97:2001;135-139.
7. Crowley P. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials - 1972-1994. Am J Obstet Gynecol. 173:1995;322-335.
8. Report of the consensus development conference on the effects of corticosteroids for fetal maturation on perinatal outcomes. November 1994;National Institute of Child Health and Human Development, Bethesda, Maryland. NIH publication no. 95-3784.
9. Ballard P.L., Ballard R.A. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol. 173:1995;254-262.
10. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol. 141:1981;276-287.
11. Gamsu H.R., Mullinger B.M., Donnai P.et al. Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants. Br J Obstet Gynaecol. 96:1989;401-410.
12. Baud O., Foix-Helias L., Kaminski M.et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med. 341:1999;1190-1196.
13. Gilstrap L.C. III, D'Alton M.E., Berkowitz R. Repeat antenatal corticosteroids: a time for caution. Contemp Ob/Gyn. 47:2002;32-43.
14. Quinlivan J.A., Evans S.F., Dunlop S.A.et al. Use of corticosteroids by Australian obstetricians. Aust N Z J Obstet Gynaecol. 38:1998;1-7.
15. Erickson K., Schmidt L., Santesso D.L., Schulkin J., Gregory K., Hobel C. Obstetrician-gynecologists' knowledge and training about antenatal corticosteroids. Obstet Gynecol. 97:2001;140-146.
16. Doyle M., Hamilton R., Johanson R., O'Brien S. The use of corticosteroids for maturation of fetal lungs in patients with preterm prelabour rupture of the membranes. Br J Obstet Gynaecol. 101:1994;1078-1079.
17. Smolders-de Haas H., Neuvel J., Schmand B., Treffers P.E., Koppe J.G., Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10 to 12 year follow-up. Pediatrics. 86:1990;65-70.
18. Doyle L.W., Ford G.W., Rickards A.L.et al. Antenatal corticosteroids and outcome at 14 years of age in children with birth weight less than 1501 grams. Pediatrics. 106:2000;e2.
19. Mercer B.M. Preterm premature rupture of the membranes. Obstet Gynecol. 101:2003;178-193.
20. Committee opinion #147. December 1994;ACOG, Washington DC.
21. Arias F., Knight A.B., Tomich P.B. A retrospective study on the effects of steroid administration and prolongation of the latent phase in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol. 154:1986;1059-1063.
22. Chapman S.J., Hauth J.C., Bottoms S.F.et al. Benefits of maternal corticosteroid therapy in infants weighing < 1000 grams at birth after preterm rupture of the amnion. Am J Obstet Gynecol. 180:1999;677-678.
23. Van Dorsten J.P., Horger E.O., Miller M.C. Preterm rupture of the membranes: combination therapy. Am J Obstet Gynecol. 153:1985;147-153.
24. Garite T.J., Freeman R.K., Linzey E.M.et al. Prospective randomized study of corticosteroids in the management of premature rupture of the membranes and the premature gestation. Am J Obstet Gynecol. 141:1981;508-515.
25. Iams J.D., Talbert M.L., Barrows H.et al. Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation versus use of steroids and timed delivery. Am J Obstet Gynecol. 151:1985;32-38.
26. Nelson L.H., Meis P.J., Hatjis C.G., Ernest J.M., Dillard R., Schey H.M. Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstet Gynecol. 66:1985;55-58.
27. Garite T.J., Rumney P.J., Briggs G.G.et al. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol. 166:1992;646-651.
28. Gardner M.O., Papile L.A., Wright L.L. Antenatal corticosteroids in pregnancies complicated by preterm premature rupture of membranes. Obstet Gynecol. 90:1997;851-853.
29. Vermillion S.T., Soper D.E., Bland M.L., Newman R.B. Effectiveness of antenatal corticosteroid administration after preterm premature rupture of the membranes. Am J Obstet Gynecol. 183:2000;925-929.
30. The use of dexamethasone in women with preterm premature rupture of membranes - a multicentre, double-blind, placebo-controlled, randomized trial. S Afr Med J. 89:1999;865-870.
31. Harding J.E., Pang J., Knight D.B., Liggins G.C. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? Am J Obstet Gynecol. 184:2001;131-139.
32. Jobe A.H., Newnham J.P., Willet K.E.et al. Endotoxin induced lung maturity in preterm lambs is not mediated by cortisol. Am J Respir Crit Care Med. 162:2000;1656-1661.
33. Sims E.J., Vermillion S.T., Soper D.E. Preterm premature rupture of the membranes is associated with a reduction in neonatal respiratory distress syndrome. Am J Obstet Gynecol. 187:2002;268-272.
34. Newnham J.P., Moss T.J., Padbury J.F.et al. The interactive effects of endotoxin with prenatal glucocorticoids on short-term lung function in sheep. Am J Obstet Gynecol. 185:2001;190-197.
35. Jobe A.H. Indications for and questions about antenatal teroids. Adv Pediatr. 49:2002;227-243.
36. Shimoya K., Matsuzaki N., Taniguchi T.et al. Interleukin-8 in cord sera: a sensitive and specific marker for the detection of preterm chorioamnionitis. J Infect Dis. 165:1992;957-960.
37. Elimian A., Verma U., Beneck D.et al. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet Gynecol. 96:2000;333-336.
38. Costeloe K., Hennessy E., Gibson A.T.et al. The EPICure study: Outcomes to discharge from hospital for infants born at the threshold of vialility. Pediatrics. 106:2000;659-671.
39. Bunton T.E., Plopper C.G. Triamcinolone-induced structural alterations in the development of the lung of the fetal rhesus macaque. Am J Obstet Gynecol. 148:1984;203-215.
40. Jerome C.P., Hendrickx A.G. Comparative teratogenicity of triamcinolone acetonide and dexamethasone in the rhesus monkey (Macaca mulatta). J Med Primatol. 17:1988;195-203.
41. Trenque T., Lamiable D., Vistelle R., Millart H., Leperre A., Choisy H. Comparative pharmacokinetics of two diastereoisomers dexamethasone and betamethasone in plasma and cerebrospinal fluid in rabbits. Fundam Clin Pharmacol. 8:1994;430-436.
42. Ballard P.L., Liggins G.C. Glucocorticoid activity in cord serum: comparison of hydrocortisone and betamethasone regimens. J Pediatr. 101:1982;468-470.
43. Buttgereit F., Brand M.D., Burmester G.-R. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem Pharmacol. 58:1999;363-368.
44. Jaffuel D., Roumestan C., Balaguer P.et al. Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids. Steroids. 66:2001;597-604.
45. Tanigawa K., Nagase H., Ohmori K.et al. Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters. Int Immunopharmacol. 2:2002;941-950.
46. Buttgereit F., Wehling M., Burmester G.R. A new hypothesis of modular glucocorticoid actions: glucocorticoid treatment of rheumatic diseases revisited. Arthritis Rheum. 41:1998;761-767.
47. Schmid D., Burmester G.R., Tripmacher R., Kuhnke A., Buttgereit F. Bioenergetics of human peripheral blood mononuclear cell metabolism in quiescent, activated, and glucocorticoid-treated states. Biosci Rep. 20:2000;289-302.
48. Ozdemir H., Guvenal T., Cetin M., Kaya T., Cetin A. A placebo-controlled comparison of effects of repetitive doses of betamethasone and dexamethasone on lung maturation and lung, liver, and body weights of mouse pups. Pediatr Res. 53:2003;98-103.
49. Loeb J.N. Corticosteroids and growth. N Engl J Med. 295:1976;547-552.
50. Rayburn W.F., Christensen H.D., Gonzalez C.L. A placebo-controlled comparison between betamethasone and dexamethasone for fetal maturation: differences in neurobehavioral development of mice offspring. Am J Obstet Gynecol. 176:1997;850-851.
51. MacArthur B.A., Howie R.N., Dezoete J.A.et al. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics. 70:1982;99-105.
52. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol. 141:1981;276-287.
53. Crowley P. Prophylactic corticosteroids for preterm delivery (Cochrane review). In: The Cochrane library. Issue 3, 2003. Oxford: Update Software.
54. O'Shea T.M., Kothadia J.M., Klinepeter K.L.et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 104:1999;15-21.
55. Yeh T.F., Lin Y.J., Huang C.C.et al. Early dexamethasone therapy in preterm infants; a follow-up study. Pediatrics. 101:1998;e7.
56. Baud O., Laudenbach V., Evrard P., Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: role of preservatives. Pediatr Res. 50:2001;706-711.
57. Reist M., Marshall K.A., Jenner P., Halliwell B. Toxic effects of sulfite in combination with peroxynitrite on neuronal cells. J Neurochem. 71:1998;2431-2438.
58. Arquie C., Leroux P., Bodenant C., Laquerriere A., Marpeau L., Marret S. Glucocorticoid treatment in an ischaemic-like excitotoxic model of periventricular leukomalacia in mice. BJOG. 109:2002;989-996.
59. Ikegami M., Polk D.H., Jobe A.H.et al. Effect of interval from fetal corticosteroid treatment to delivery on postnatal lung function of preterm lambs. J Appl Physiol. 80:1996;591-597.
60. Tan R.C., Ikegami M., Jobe A.H., Yao L.Y., Possmayer F., Ballard P.L. Developmental and glucocorticoid regulation of surfactant protein mRNAs in preterm lambs. Am J Physiol. 277:1999;L1142-L1148.
61. Vidaeff A., Alcorn J. Jr., Ramin S., Gilstrap L. In vitro quantification of dexamethasome-induced SP-B expression in human lung cells. Am J Obstet Gynecol. 187:2002;S65.
62. French N.P., Hagan R., Evans S.F.et al. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol. 180:1999;114-121.
63. Banks B.A., Cnaan A., Morgan M.A.et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. Am J Obstet Gynecol. 181:1999;709-717.
64. Bloom S.L., Sheffield J.S., McIntire D.D.et al. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol. 97:2001;485-490.
65. Vermillion S.T., Soper D.E., Newman R.B. Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. Am J Obstet Gynecol. 183:2000;810-814.
66. Abbasi S., Hirsch D., Davis J.et al. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol. 182:2000;1243-1249.
67. Thorp J.A., Jones A.M., Hunt C.et al. The effect of multidose antenatal betamethasone on maternal and infant outcomes. Am J Obstet Gynecol. 184:2001;196-202.
68. Guinn D.A., Atkinson M.W., Sullivan L.et al. Single vs. weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA. 286(13):2001;1581-1587.
69. Clewell W.H. Antenatal corticoids optimal timing and dosing. OBG Management. 14(9):2002;50-58.
70. Barker D.J.P., Hales C.N., Fall C.H.D., Osmond C., Phipps K., Clark P.M.S. Type 2(non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X); Relation to reduced fetal growth. Diabetologia. 36:1993;62-67.
71. Benediktsson R., Lindsay R.M., Noble J., Seckl J.R., Edwards C.R.W. Glucocorticoid exposure in utero: a new model for adult hypertension. Lancet. 341:1993;339-341.
72. Avery M.E. Pharmacological approach to the acceleration of fetal lung maturation. Br Med Bull. 31:1975;13-17.
73. Jobe A.H., Newnham J., Willet K.et al. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids. Pediatrics. 102:1998;1116-1125.
74. Benediktsson R., Calder A.A., Edwards C.R.W., Seckl J.R. Placental 11 β-hydroxysteroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: ex vivo studies. Clin Endocrinol. 46:1997;161-166.
75. Ma X.H., Wu W.X., Nathanielsz P.W. Differential effects of natural and synthetic glucocorticoids on cytochrome 17alpha-hydroxylase (P-45017alpha) and cytochrome P-450 side-chain cleavage (P-450scc) messenger ribonucleic acid in sheep placenta. Am J Obstet Gynecol. 180:1999;1215-1221.
76. Committee Opinion #210. October 1998;ACOG, Washington, DC.
77. Obstet Gynecol. 98:2001;144-150.
78. Committee Opinion #273. May 2002;ACOG, Washington, DC.
79. Simpson K.N., Lynch S.R., Mebane F.E., Hamby T.J., Paramore C. Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and related conditions in premature infants. Am J Obstet Gynecol. 173:1995;316-321.